"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency

Clinical trial NCT01489618 · TERMINATED

Trial details

NCT number: NCT01489618
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Common Variable Immunodeficiency

Start date: 2009-06-01
Primary completion: 2013-03-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.